BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 27/12/2017

FDA Classifies Rectal Balloon for Prostate Immobilization into Class II with Special Controls

The FDA has classified the rectal balloon for prostate immobilization into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.

Source: Federal Register — Food and Drug AdministrationOpen original release →